3D bioprinted human liver tissue for direct transplantation to patients

Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using its 3D bioprinting technology, today announced its plan to develop 3D bioprinted human Read more about 3D bioprinted human liver tissue for direct transplantation to patients[…]